Balcinrenone/ dapagliflozin not checked

AstraZeneca

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
6 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“1 capsule of balcinrenone/dapagliflozin 15 mg/10 mg and 1 tablet of matching placebo for dapagliflozin 10 mg once daily, oral use”In the company’s words, NCT06307652 on ClinicalTrials.gov
Tested for
Heart Failure and Impaired Kidney Function, Renal Insufficiency, Chronic
Main trialPhase 3
“This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapagliflozin, given once daily on top of other classes of SoC, on CV death and HF events.”In the company’s words, NCT06307652 on ClinicalTrials.gov

Other drugs for Heart Failure and Impaired Kidney Function

All 42 drugs for Heart Failure and Impaired Kidney Function

Coming up2

Changes1

Last 90 days

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 16 Apr 2027 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3Recruiting 1 Jul 2030 A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Phase 2Completed 9 May 2025 Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
Phase 1Completed 28 Oct 2024 A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants
Phase 1Completed 12 Jul 2025 A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.
Phase 1Completed 6 Oct 2026 Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Balcinrenone/ dapagliflozin

Following is part of Solo: you see every change to Balcinrenone/ dapagliflozin the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in